EcoDrugPlus

Telomerase Reverse Transcriptase

Ensembl ID : ENSSPAG00000020478
Gene Symbol: TERT
3 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSSPAG00000020167
Gene Symbol: TBXAS1
3 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSSPAG00000002155
Gene Symbol: TBXA2R
3 Cross references
192 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSSPAG00000021385
Gene Symbol: TYMP
4 Cross references
172 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSSPAG00000011295
Gene Symbol: TYMS
3 Cross references
223 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSSPAG00000014968
Gene Symbol: TRHR
3 Cross references
201 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor-Like

Ensembl ID : ENSSPAG00000008848
Gene Symbol: LOC103370682
3 Cross references
193 Possible Orthologues:

Tissue Factor-Like

Ensembl ID : ENSSPAG00000008822
Gene Symbol: LOC103374736
3 Cross references
199 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSSPAG00000012024
Gene Symbol: TLR2
2 Cross references
183 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSSPAG00000007995
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSSPAG00000007983
Gene Symbol: TLR8
4 Cross references
187 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSSPAG00000010699
Gene Symbol: LOC103373033
2 Cross references
213 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).